Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...
In the dynamic landscape of oncology, drug development presents towering challenges. Historically marked by high attrition ...
GLP-tox study reinforces favorable safety profile of Tiprelestat Phase II Study in Pulmonary Arterial Hypertension (PAH) to be initiated ...
A novel treatment (MA-5) developed by a Tohoku University-led research team will soon undergo phase II clinical trials at ...
Under the partnership, Lilly will pay IU up to $40 million to build clinical trial infrastructure, accelerate access to ...
GTA182 demonstrates favorable safety, dose-proportional pharmacokinetics, robust PRMT5 pathway inhibition, and encouraging early antitumor ...
1don MSN
From lab to clinic: Phase I trial of promising combination therapy for resistant ovarian cancer
Researchers at the University of Colorado Cancer Center have discovered a novel therapy combination that could offer new hope ...
GRIN Therapeutics, Inc., a leader in the development of targeted disease-specific therapies to treat serious ...
The Phase II OCULE-01 study in uveal melanoma started in March 2025, the PULMO-01 study in non-small cell lung cancer (NSCLC) started in May 2025 and the HEMA-MED Phase I/II study in myelofibrosis ...
Company plans to discuss results and regulatory pathway of IGV-001 with U.S. FDA in the coming months -- Imvax, Inc., a clinical-stage biotechnology company developing personalized, whole ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback